Cargando…

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

Detalles Bibliográficos
Autores principales:	Berry, John S, Schneble, Erika J, Trappey, Alfred F, Vreeland, Timothy J, Clifton, Guy T, Hale, Diane F, Sears, Alan K, Ponniah, Sathibalan, Mittendorf, Elizabeth A, Peoples, George E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991347/ http://dx.doi.org/10.1186/2051-1426-1-S1-P200

Ejemplares similares

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
por: Greene, Julia, et al.
Publicado: (2014)

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
por: Schneble, Erika J, et al.
Publicado: (2013)

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
por: Greene, Julia, et al.
Publicado: (2014)

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
por: Jackson, Doreen O., et al.
Publicado: (2016)

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine
por: Jackson, Doreen, et al.
Publicado: (2015)

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation
por: Berry, John S, et al.
Publicado: (2016)

Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development
por: Berry, JS, et al.
Publicado: (2017)

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients
por: Brown, Tommy A., et al.
Publicado: (2019)

Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes
por: Vreeland, Timothy J, et al.
Publicado: (2017)

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
por: Mittendorf, Elizabeth A., et al.
Publicado: (2016)

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
por: Brown, Tommy A., et al.
Publicado: (2020)

Preclinical testing of a novel personalized cancer vaccine for all solid tumors and all patients
por: Jackson, Doreen, et al.
Publicado: (2015)

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
por: Adams, Alexandra M., et al.
Publicado: (2021)

Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016)

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
por: Li, Xiaofan, et al.
Publicado: (2023)

Folate intake and the risk of endometrial cancer: A meta-analysis
por: Du, Li, et al.
Publicado: (2016)

Adjuvant therapy for endometrial cancer
por: DeLeon, Maria C., et al.
Publicado: (2014)

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement
por: Kemp Bohan, Phillip M., et al.
Publicado: (2020)

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
por: Vreeland, Timothy J., et al.
Publicado: (2021)

The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
por: Crane, Lucia M. A., et al.
Publicado: (2011)

Controversies in the Adjuvant Therapy of Endometrial Cancer
por: Hsiao, Sheng-Mou, et al.
Publicado: (2011)

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
por: McCarthy, Patrick M., et al.
Publicado: (2023)

Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
por: O'Shannessy, Daniel J., et al.
Publicado: (2012)

Erratum to: The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
por: Crane, Lucia M. A., et al.
Publicado: (2012)

Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
por: Basal, Eati, et al.
Publicado: (2009)

Brain Uptake of Folate Forms in the Presence of Folate Receptor Alpha Antibodies in Young Rats: Folate and Antibody Distribution
por: Bobrowski-Khoury, Natasha, et al.
Publicado: (2023)

Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging
por: Hekman, Marlène C. H., et al.
Publicado: (2017)

Chemoprevention in familial adenomatous polyposis: past, present and future
por: Kemp Bohan, Phillip M., et al.
Publicado: (2020)

Folate Receptor Alpha: A New Tool in the Diagnosis and Treatment of Lung Cancer
por: Wood, Laura D.
Publicado: (2012)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Adjuvant and first line chemotherapy use for endometrial cancer
por: Knisely, Anne, et al.
Publicado: (2022)

Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic
por: Chick, Robert Connor, et al.
Publicado: (2020)

High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer
por: Yazaki, Shu, et al.
Publicado: (2022)

Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?
por: Zagouri, Flora, et al.
Publicado: (2010)

Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
por: Donovan, Elysia, et al.
Publicado: (2018)

Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives
por: Giustozzi, Alessandra, et al.
Publicado: (2021)

Endocytosis of GPI-linked membrane folate receptor-alpha
Publicado: (1996)

Maximizing Benefit of Virtual Learning: Lessons From the Coronavirus Disease 2019 Pandemic
por: Carpenter, Elizabeth L., et al.
Publicado: (2022)

Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha
por: Razaghi, Ali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9flhihvpc9cgdnm2mfenroqc0